Beskrivelse
Krav
IPC-klasse
Fullmektig i Norge:
Org.nummer: 982702887
- Org.nummer:
- Foretaksnavn:
- Foretaksform:
- Næring:
-
Forretningsadresse:
Fullmektig i EP:
2014.02.04, US 201461935833 P
A D KAISER ET AL: "Towards a commercial process for the manufacture of genetically modified T cells for therapy", CANCER GENE THERAPY, vol. 22, no. 2, 23 January 2015 (2015-01-23), pages 72 - 78, XP055211554, ISSN: 0929-1903, DOI: 10.1038/cgt.2014.78 (B1)
WO-A2-2013/040557 (B1)
BARBARA TUMAINI ET AL: "Simplified process for the production of anti-CD19-CAR-engineered T cells", CYTOTHERAPY, vol. 15, no. 11, 1 November 2013 (2013-11-01), pages 1406 - 1415, XP055211897, ISSN: 1465-3249, DOI: 10.1016/j.jcyt.2013.06.003 (B1)
BEYER, M ET AL.: "CD 4+ CD 25highFOXP3+ Regulatory T Cells In Peripheral Blood Are Primarily Of Effector Memory Phenotype.", JCO., vol. 25, no. 18, 20 June 2007 (2007-06-20), pages 2628 - 263, XP055237239, ISSN: 0732-183x (B1)
C.H.J. LAMERS ET AL: "Retronectin -assisted retroviral transduction of primary human T lymphocytes under good manufacturing practice conditions: tissue culture bag critically determines cell yield", CYTOTHERAPY, vol. 10, no. 4, 1 January 2008 (2008-01-01), GB, pages 406 - 416, XP055390268, ISSN: 1465-3249, DOI: 10.1080/14653240801982961 (B1)
E COSTELLO ET AL: "Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors", GENE THERAPY, vol. 7, no. 7, 1 April 2000 (2000-04-01), GB, pages 596 - 604, XP055455146, ISSN: 0969-7128, DOI: 10.1038/sj.gt.3301135 (B1)
EP-A1- 2 267 118 (B1)
KATSUYUKI DODO ET AL: "An Efficient Large-Scale Retroviral Transduction Method Involving Preloading the Vector into a RetroNectin-Coated Bag with Low-Temperature Shaking", PLOS ONE, vol. 9, no. 1, 15 January 2014 (2014-01-15), pages e86275, XP055109271, ISSN: 1932-6203, DOI: 10.1371/journal.pone.0086275 (B1)
KOCHENDERFER, JN ET AL.: "Construction And Pre-Clinical Evaluation Of An Anti- CD 19 Chimeric Antigen Receptor.", J IMMUNOTHER., vol. 32, no. 7, September 2009 (2009-09-01), pages 689 - 702, XP009133189 (B1)
LAMERS C H J ET AL: "Protocol for gene transduction and expansion of human T lympocytes for clinical immunogene therapy of cancer", CANCER GENE THERAPY, APPLETON & LANGE, GB, vol. 9, 1 January 2002 (2002-01-01), pages 613 - 623, XP003020145, ISSN: 0929-1903, DOI: 10.1038/SJ.CGT.7700477 (B1)
TANGYING LILY LU ET AL: "A Rapid Cell Expansion Process for Production of Engineered Autologous CAR-T Cell Therapies", HUMAN GENE THERAPY METHODS, vol. 27, no. 6, 1 December 2016 (2016-12-01), pages 209 - 218, XP055389324, ISSN: 1946-6536, DOI: 10.1089/hgtb.2016.120 (B1)
WO-A1-2012/138475 (B1)
WO-A1-2013/072288 (B1)
WO-A1-2015/162211 (B1)
ANDREW R. MEDVEC ET AL: "Improved Expansion and In Vivo Function of Patient T Cells by a Serum-free Medium", MOLECULAR THERAPY- METHODS & CLINICAL DEVELOPMENT, vol. 8, 1 March 2018 (2018-03-01), GB, pages 65 - 74, XP055549838, ISSN: 2329-0501, DOI: 10.1016/j.omtm.2017.11.001 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3102609)
|
Utgående
EP Registreringsbrev (3210) (PTEP3102609)
|
Innkommende
Korrespondanse (Hovedbrev inn)
|
Utgående
EP Formelle mangler
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Neste fornyelse/årsavgift:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 11. avg. år (EP) | 2025.02.12 | 4550 | CPA GLOBAL LIMITED | Betalt og godkjent |
32414118 expand_more expand_less | 2024.11.05 | 7150 | ZACCO NORWAY AS | Betalt |
Valideringsgebyr EP-patent
7150 = 1 X 7150
|